BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 19374334)

  • 1. Molecular regulation of tumor angiogenesis and perfusion via redox signaling.
    Miller TW; Isenberg JS; Roberts DD
    Chem Rev; 2009 Jul; 109(7):3099-124. PubMed ID: 19374334
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholamines regulate tumor angiogenesis.
    Chakroborty D; Sarkar C; Basu B; Dasgupta PS; Basu S
    Cancer Res; 2009 May; 69(9):3727-30. PubMed ID: 19383906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redundant angiogenic signaling and tumor drug resistance.
    Gacche RN; Assaraf YG
    Drug Resist Updat; 2018 Jan; 36():47-76. PubMed ID: 29499837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why haven't we cured cancer?
    Harding E
    Lancet Oncol; 2017 Jul; 18(7):861-862. PubMed ID: 28677566
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Angiogenesis agents.
    Marcinkiewicz C
    Curr Pharm Des; 2007; 13(35):3543-4. PubMed ID: 18220790
    [No Abstract]   [Full Text] [Related]  

  • 6. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
    Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
    Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial foreword special issue: "Angiogenesis-convergent or divergent, that is the question: Research toward targeted strategies in oncology".
    Cai J
    Cancer Lett; 2016 Oct; 380(2):523-524. PubMed ID: 27032878
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance.
    Cao Y; Zhong W; Sun Y
    Semin Cancer Biol; 2009 Oct; 19(5):338-43. PubMed ID: 19481151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel drug targets for angiostatic cancer therapy; it takes two to tango.
    Thijssen VL; van Beijnum JR; Mayo KH; Griffioen AW
    Curr Pharm Des; 2007; 13(35):3576-83. PubMed ID: 18220794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting angiogenic metabolism in disease.
    Li X; Carmeliet P
    Science; 2018 Mar; 359(6382):1335-1336. PubMed ID: 29567696
    [No Abstract]   [Full Text] [Related]  

  • 11. The Discovery of Tumor Angiogenesis Factors: A Historical Overview.
    Ribatti D
    Methods Mol Biol; 2016; 1464():1-12. PubMed ID: 27858351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the angiopoietin/Tie2 pathway: cutting tumor vessels with a double-edged sword?
    Cascone T; Heymach JV
    J Clin Oncol; 2012 Feb; 30(4):441-4. PubMed ID: 22184396
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiology of tumor neovascularization.
    Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
    Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.
    Welti J; Loges S; Dimmeler S; Carmeliet P
    J Clin Invest; 2013 Aug; 123(8):3190-200. PubMed ID: 23908119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenic switch in carcinogenesis.
    Baeriswyl V; Christofori G
    Semin Cancer Biol; 2009 Oct; 19(5):329-37. PubMed ID: 19482086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-proteasome system meets angiogenesis.
    Rahimi N
    Mol Cancer Ther; 2012 Mar; 11(3):538-48. PubMed ID: 22357635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
    Gacche RN; Meshram RJ
    Biochim Biophys Acta; 2014 Aug; 1846(1):161-79. PubMed ID: 24836679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targets in the inhibition of angiogenesis.
    Dudek AZ; Pawlak WZ; Kirstein MN
    Expert Opin Ther Targets; 2003 Aug; 7(4):527-41. PubMed ID: 12885272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies.
    Ye L; Jiang WG
    Cancer Lett; 2016 Oct; 380(2):586-597. PubMed ID: 26639195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of angiogenesis in cancers.
    Pang RW; Poon RT
    Vasc Health Risk Manag; 2006; 2(2):97-108. PubMed ID: 17319453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.